Conference Co-Chairs:

  • Ron-Liu Ron Liu, PhD MBA
    President & Chief Executive Officer
    AustarPharma
  • Mike-Pikal Michael Pikal, PhD
    Professor and Pfizer Distinguished Chair, Pharmaceutical Technology
    University of Connecticut

Uncovering Novel Advances in Enhancing Solubility, Amorphous Forms, Bioavailability & Lipid-Based Formulation of Drugs

With ever-increasing numbers of poorly soluble drugs coming to market, the 4th Improving Solubility conference is aimed at helping scientists adopt novel solutions to maximize time-to-market and discover the latest strategies for successful drug development pipelines.

Attendees will benefit from industry presentations from AstraZeneca, Merck, Novartis, Pfizer, Sanofi-Aventis, Bristol-Myers Squibb, Lundbeck and many more pharmaceutical, biotech and academic experts.

New addition to Improving Solubility agenda: Pre-Conference Master Class Solubility Enhancement & Techniques

Don’t miss the Networking Dinner!

In addition to discussions throughout the main conference and pre-conference workshops, we’ll continue networking and learning by joining industry professionals during the inaugural Networking Dinner on the evening of Tuesday, March 30th. When registering, be sure to ask about attending, as a separate booking will be required.

In-depth Case Study Examples to Improve Solubility Include:

  • Nanocrystalline drug-polymer solid dispersions for poorly water-soluble drugs
  • The role and function of solubility measurement from a central laboratory in drug discovery
  • Implication of BCS: Solubility and permeability class on drug formulation
  • Lipid-based drug delivery to effectively overcome physical and biological barriers
  • Oral lipid-based formulations for the enhancement of poorly soluble compound delivery
  • API crystal forms and their bioavailabilities
  • Novel strategies for salt selection concerning solubility enhancement, salt stability and stabilization

Testimonials

Excellent networking and diverse sessions, good to have theoretical discourse
Dr. Jeff Skell, Director, DMPL and Pharmaceutics, Genzyme
Very good! Great mix of details (technical) plus examples
Dr. Debra Walker, Research Fellow, Merck & Co.
Great networking and discussion sessions
Dr. Ly Phan, Senior Director, Medicinal Chemistry, Enanta Pharmaceuticals
Sponsors Media Partners
Animated sponsors MediaPartners

[ Register Now ]